AcelRx Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
103,663.00
75,350.00
113,464.00
80,310.00
60,469.00
105,715
Total Accounts Receivable
-
-
3,286.00
5,833.00
1,533.00
401
Inventories
-
-
466.00
2,154.00
956.00
854
Other Current Assets
897.00
948.00
1,731.00
756.00
455.00
1,024
Total Current Assets
104,560.00
76,298.00
118,947.00
89,053.00
63,413.00
107,994
Net Property, Plant & Equipment
5,179.00
9,818.00
8,610.00
10,712.00
11,051.00
11,483
Total Investments and Advances
250.00
250.00
178.00
178.00
178.00
178
Long-Term Note Receivable
-
-
-
-
703.00
351
Other Assets
42.00
81.00
50.00
50.00
207.00
527
Total Assets
110,031.00
86,447.00
127,785.00
99,993.00
75,552.00
120,533
ST Debt & Current Portion LT Debt
-
6,859.00
4,659.00
3,676.00
8,331.00
Accounts Payable
2,341.00
2,431.00
1,561.00
1,558.00
1,424.00
Other Current Liabilities
4,527.00
4,441.00
6,560.00
4,957.00
3,905.00
Total Current Liabilities
6,868.00
13,731.00
12,780.00
10,191.00
13,660.00
Long-Term Debt
14,364.00
18,328.00
80,141.00
90,860.00
94,353.00
Other Liabilities
15,640.00
7,732.00
1,751.00
4,279.00
4,048.00
Total Liabilities
36,872.00
39,791.00
94,672.00
105,330.00
112,061.00
Common Equity (Total)
73,159.00
46,656.00
33,113.00
5,337.00
36,509.00
Total Shareholders' Equity
73,159.00
46,656.00
33,113.00
5,337.00
36,509.00
Total Equity
73,159.00
46,656.00
33,113.00
5,337.00
36,509.00
Liabilities & Shareholders' Equity
110,031.00
86,447.00
127,785.00
99,993.00
75,552.00
About AcelRx Pharmaceuticals
View Profile
